ABSTRACT
IL-6 is an important signaling molecule in the CNS. CNS neurons express IL-6 receptors and their signal transduction molecules, consistent with a role for IL-6 in neuronal physiology. Research indicates that IL-6 levels are low in the normal brain but can be significantly elevated in CNS injury and disease. Relatively little is known about how the elevated levels of IL-6 affect neurons. In the current study we show that under conditions of chronic exposure, IL-6 induces alterations in the level of protein expression in developing CNS cells. Such changes may play a role in the altered CNS function observed in CNS conditions associated with elevated levels of IL-6 in the CNS.
Subject(s)
Adaptation, Physiological/immunology , Cerebellar Cortex/cytology , Cerebellar Cortex/immunology , Interleukin-6/pharmacology , Animals , Cell Differentiation/immunology , Cells, Cultured , Cerebellar Cortex/metabolism , Female , Interleukin-6/biosynthesis , Male , Mice , Mice, Transgenic , Neuroglia/cytology , Neuroglia/immunology , Neuroglia/metabolism , Protein Biosynthesis/immunology , Rats , Rats, Sprague-Dawley , Recombinant Proteins/biosynthesis , Recombinant Proteins/pharmacology , Time FactorsABSTRACT
Excess NaCl increases blood pressure in some strains of animals but not others. An 8% NaCl diet did not change renal thiazide receptor (TZR) density in two salt-resistant normotensive rat strains (Wistar-Kyoto and Sprague-Dawley) [Fanestil, D. D., D. A. Vaughn, and P. Blakely. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R1241-R1245, 1997]. However, the renal response to salt differs in normal and hypertensive kidneys [Rettig, R., N. Bandelow, O. Patschan, B. Kuttler, B. Frey, and A. Uber. J. Hum. Hypertens. 10: 641-644, 1996]. Therefore, we examined two strains with salt-aggravated hypertension. Renal TZR did not change when Dahl-S (salt sensitive) animals became hypertensive with 8% dietary NaCl. In contrast, renal TZR decreased 34%, whereas blood pressure increased further, in SHR with 8% dietary NaCl. Blood pressure increased after NG-nitro-L-arginine in SHR, but renal TZR did not change, indicating the salt-induced decrease in TZR in SHR cannot be attributed nonspecifically to elevated arterial pressure. We conclude that the renal response to NaCl-induced increases in blood pressure can be genetically modulated independently of the genes that mediate either the primary hypertension or the salt sensitivity of the hypertension. This finding may be of use in future studies directed at identifying genotypes associated with salt-dependent hypertension.
Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Hypertension/metabolism , Kidney/metabolism , Receptors, Drug/genetics , Receptors, Drug/metabolism , Sodium Chloride/administration & dosage , Symporters , Animals , Diet , Drug Resistance , Enzyme Inhibitors/pharmacology , Male , Nitric Oxide Synthase/antagonists & inhibitors , Nitroarginine/pharmacology , Rats , Rats, Inbred Dahl/physiology , Rats, Inbred SHR , Sodium Chloride/pharmacology , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3ABSTRACT
This study reports for the first time a relationship between dietary Mg and the renal thiazide-sensitive Na-Cl cotransporter (TZR, measured by saturation binding with 3H-metolazone). Ion-selective electrodes measured plasma ionized magnesium (PMg++), calcium (PCa++), and potassium (PK+). Restricting dietary Mg for 1 wk decreased PMg++ 18%, TZR 25%, and renal excretion of magnesium (UMg) and calcium (UCa) more than 50% without changing PCa++, PK+, or plasma aldosterone. A low Mg diet for 1 d significantly decreased PMg++, TZR, UMg and UCa. Return of dietary Mg after 5 d of Mg restriction restored PMg++ and TZR toward normal. In the control, Mg-deficient, and Mg-repleting animals, TZR correlated with PMg++ (r = 0.86) and with UMg (r = 0.87) but not UCa (r = 0.09). Increasing oral intake of Mg for 1 wk increased PMg++ 14%, TZR 32%, UMg 74%, and UCa more than fourfold without changing PCa++ or PK+. In contrast, increasing dietary Ca content from 0.02% to 1.91% did not change TZR, but increased UCa fivefold without changing PCa++. Hormonal mediators (if any) involved in the relationship between dietary Mg and TZR remain to be elucidated, as does the relationship between TZR and tubular reabsorption of Mg.
Subject(s)
Calcium, Dietary/administration & dosage , Carrier Proteins/metabolism , Kidney Tubules, Distal/metabolism , Magnesium/administration & dosage , Magnesium/blood , Receptors, Drug/metabolism , Symporters , Administration, Oral , Analysis of Variance , Animals , Calcium/blood , Calcium/deficiency , Calcium/urine , Carrier Proteins/analysis , Carrier Proteins/drug effects , Diet , Kidney Tubules, Distal/drug effects , Linear Models , Magnesium/urine , Male , Potassium/blood , Rats , Rats, Sprague-Dawley , Receptors, Drug/analysis , Receptors, Drug/drug effects , Reference Values , Sodium Chloride/metabolism , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3ABSTRACT
We tested the postulate that the renal density of the thiazide-inhibitable Na-Cl cotransporter or thiazide receptor (TZR) is modulated as part of the renal homeostatic response to changes in dietary intake of NaCl or KCl. Renal excretion of NaCl or KCl varied > 10-fold in response to alterations in oral intake. Renal TZR density was quantitated by binding of [3H]metolazone to renal membranes. Renal TZR density was not altered by sodium deficit (with increased plasma aldosterone concentration), by sodium surfeit (8% NaCl content of diet), by potassium deficit (with hypokalemia), or by potassium surfeit (drinking 1% KCl solution). Unexpectedly, we conclude that regulation of the renal density of TZR is not part of the renal homeostatic responses that adjust excretion of NaCl and KCl to changes in dietary intake of NaCl or KCl.
Subject(s)
Carrier Proteins/drug effects , Carrier Proteins/metabolism , Kidney/metabolism , Potassium Chloride/administration & dosage , Receptors, Drug/drug effects , Receptors, Drug/metabolism , Sodium Chloride/administration & dosage , Symporters , Aldosterone/blood , Animals , Chlorides/urine , Diet , Male , Natriuresis/physiology , Potassium/urine , Potassium Chloride/pharmacology , Rats , Rats, Sprague-Dawley , Sodium Chloride/pharmacology , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3ABSTRACT
The renal responses to metabolic acidosis/alkalosis involve changes in the proximal tubule, loop of Henle, and collecting ducts. We tested for acid- or base-induced changes in the distal convoluted tubule (DCT) by examining the renal density of the DCT's receptor for thiazide-type diuretics (TZR), as estimated by the binding of [3H]metolazone in Wistar-Kyoto rats. TZR density significantly decreased by 17% in rats ingesting NH4Cl for 3.5 days and by nearly 30% after 7 days; TZR increased up to 40% in rats ingesting NaHCO3 for 2-4 days but was no longer significantly increased after 7 days. Urinary excretion of chloride increased as renal density of the TZR decreased, a finding consistent with the interpretation that acidosis/alkalosis not only altered TZR density but coordinately altered reabsorption of NaCl by the thiazidesensitive Na-Cl cotransporter. The result is that delivery of Na from DCT is enhanced during acidosis and decreased during alkalosis, assisting in compensatory changes in distal nephron secretion of hydrogen ion. The integrated renal response to metabolic acidosis/alkalosis involves a decrease in renal TZR with acidosis and an increase in TZR with alkalosis.
Subject(s)
Acid-Base Equilibrium , Carrier Proteins/metabolism , Kidney Tubules, Distal/metabolism , Receptors, Drug/metabolism , Symporters , Ammonium Chloride/pharmacology , Animals , Male , Rats , Rats, Inbred WKY , Sex Characteristics , Sodium Bicarbonate/administration & dosage , Sodium Bicarbonate/pharmacology , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3 , Time FactorsABSTRACT
We previously reported that salmon calcitonin, but not rat calcitonin, increased renal thiazide receptor (TZR) density and decreased renal calcium [urinary calcium excretion (U(Caex))] in the rat. Since calcitonins, islet amyloid polypeptide (amylin), calcitonin-gene related peptide (CGRP), and adrenomedullin interact with a family of calcitonin-related receptors, we examined the effects of these peptides on 1) TZR density, as quantitated by binding of [3H]metolazone to renal membranes; 2) plasma ionic composition; and 3) urinary electrolyte excretion. Subcutaneous amylin both increased TZR density nearly twofold and decreased U(Caex), with maximal effects by 24 h. The decreased U(Caex) occurred with plasma amylin levels in the physiological range, whereas the increased TZR did not reach maximum even with plasma amylin >100 times above normal. Similar doses of adrenomedullin increased TZR density modestly but without effect on U(Caex), whereas CGRP did not alter TZR density and tended to increase U(Caex). We propose that U(Caex) and TZR density in the rat kidney are regulated by rat amylin but not by rat calcitonin.
Subject(s)
Amyloid/pharmacology , Calcitonin Gene-Related Peptide/pharmacology , Calcium/urine , Carrier Proteins/metabolism , Kidney/physiology , Peptides/pharmacology , Receptors, Drug/metabolism , Symporters , Adrenomedullin , Animals , Antihypertensive Agents/pharmacology , Benzothiadiazines , Blood Pressure/drug effects , Body Weight/drug effects , Carrier Proteins/drug effects , Diuretics , Electrolytes/blood , Electrolytes/urine , Glomerular Filtration Rate/drug effects , Hematocrit , Islet Amyloid Polypeptide , Kidney/drug effects , Male , Rats , Rats, Sprague-Dawley , Receptors, Drug/drug effects , Salmon , Sodium Chloride Symporter Inhibitors/pharmacokinetics , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3 , Species SpecificityABSTRACT
Thiazide diuretic drugs act in the distal convoluted tubule (DCT) to inhibit a Na+Cl- cotransporter and enhance reabsorption of luminal calcium. The density of receptors for thiazides in the rat DCT is known to be increased by adrenocortical steroids, furosemide, and bendroflumethiazide, but decreased by ischemia. Because the DCT is a physiologic site of action by calcitonin and parathyroid hormone, this study examined the effects of these calcitropic hormones in thyroparathyroidectomized Sprague-Dawley rats on (1) the density of the rat thiazide receptor (TZR), as quantitated by binding of (3H)metolazone to renal membranes, and (2) urinary electrolyte excretion rate. Salmon calcitonin (sCT) (20 to 100 ng/h) (1) increased the density of the renal TZR twofold, an effect that is maximal by 6 h after sCT administration, and (2) decreased urinary calcium excretion rate. Adequate dietary calcium must be provided for the effects of sCT to be observed. Regression analysis demonstrated that renal TZR density correlated negatively with total urinary calcium excretion rate but not with plasma calcium ion concentration. In addition, neither rat calcitonin (rCT), at doses that cause hypocalcemia, nor parathyroid hormone, at doses that cause hypercalcemia, produce direct effects on TZR density in the DCT of the thyroparathyroidectomized rat. Our findings indicate that upregulation of TZR by sCT, which occurs independently of plasma calcium-ion concentration, is likely via a calcitonin-like receptor other than that for rat calcitonin itself.
Subject(s)
Benzothiadiazines , Calcitonin/pharmacology , Calcium/urine , Carrier Proteins/biosynthesis , Receptors, Drug/biosynthesis , Sodium Chloride Symporter Inhibitors/pharmacology , Symporters , Teriparatide/pharmacology , Thyroxine/pharmacology , Up-Regulation/drug effects , Animals , Calcium, Dietary/pharmacology , Carrier Proteins/genetics , Diuretics , Kidney Tubules, Distal/metabolism , Metolazone/metabolism , Parathyroidectomy , Rats , Rats, Inbred WKY , Rats, Sprague-Dawley , Receptors, Drug/genetics , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3 , ThyroidectomyABSTRACT
Acetaminophen is the most commonly reported drug overdose in the United States. Acute renal failure occurs in less than 2% of all acetaminophen poisonings and 10% of severely poisoned patients. At the therapeutic dosages, acetaminophen can be toxic to the kidneys in patients who are glutathione depleted (chronic alcohol ingestion, starvation, or fasting) or who take drugs that stimulate the P-450 microsomal oxidase enzymes (anticonvulsants). Acute renal failure due to acetaminophen manifests as acute tubular necrosis (ATN). ATN can occur alone or in combination with hepatic necrosis. The azotemia of acetaminophen toxicity is typically reversible, although it may worsen over 7 to 10 days before the recovery of renal function occurs. In severe overdoses, renal failure coincides with hepatic encephalopathy and dialysis may be required. Recognition of acetaminophen nephropathy requires the following: (1) a thorough drug history, including over-the-counter medications such as Tylenol or Nyquil; (2) knowledge of the risk factors that lessen its margin of safety at therapeutic ingestions, i.e., alcoholism; and (3) consideration of acetaminophen in the differential diagnosis of patients who present with combined hepatic dysfunction and ATN.
Subject(s)
Acetaminophen/poisoning , Acute Kidney Injury/chemically induced , Acetaminophen/metabolism , Acetaminophen/pharmacology , Acute Kidney Injury/diagnosis , Acute Kidney Injury/physiopathology , Adult , Diagnosis, Differential , Drug Overdose , Female , Humans , Nonprescription Drugs/poisoning , Prognosis , Risk FactorsABSTRACT
Emboli to the renal arteries occurs most often in patients with underlying cardiac disease. Hematuria is a common feature of renal infarction, but the finding of erythrocyte casts in cases of renal infarction has not been commonly reported. We report a case of renal artery embolization in a patient who had transient nephritic urine sediment, and review the significance of this finding.
Subject(s)
Embolism/urine , Hematuria/etiology , Infarction/urine , Kidney/blood supply , Renal Artery Obstruction/urine , Adult , Alcoholism/complications , Cardiomyopathy, Dilated/complications , Humans , MaleABSTRACT
The density of the rat renal pharmacologic receptor for thiazide-type diuretics, as quantitated by the maximal specific binding of (3H)metolazone, decreased to one-third normal after adrenalectomy. Selective glucocorticoid (dexamethasone or RU-28362) replacement increased thiazide receptor density to or above the normal level over the dose range of steroid that decreased thymus weight, which served as a bioassay for glucocorticoid activity. Mineralocorticoid (fludrocortisone or aldosterone), in doses that did not decrease thymus weight, also increased thiazide diuretic receptor density to or above normal. The addition of glucocorticoid (RU-28362) to maximal aldosterone increased thiazide receptor above that produced by aldosterone alone and to threefold normal. Similarly, the addition of aldosterone to high-dose RU-28362 also increased thiazide receptor density above that produced by the glucocorticoid alone and to threefold normal. Hence, the effects of glucocorticoids and mineralocorticoids appeared to be additive. The increase in renal thiazide receptor density produced by fludrocortisone, at a dose that elicited both mineralocorticoid and glucocorticoid effects, was unrelated to the basal (prethiazide) renal excretion of sodium, potassium, chloride, or calcium. However, fludrocortisone-pretreated animals responded to bendroflumethiazide with a greater natriuresis than did controls. In addition, the magnitudes of the thiazide-elicited natriuresis and chloriuresis correlated significantly with thiazide receptor. It was concluded that both the density of the renal thiazide receptor and the quantity of sodium and chloride reabsorbed by the thiazide-sensitive Na-Cl cotransporter in the kidney are under adrenocortical regulation.
Subject(s)
Aldosterone/pharmacology , Carrier Proteins/drug effects , Kidney/chemistry , Receptors, Drug/drug effects , Sodium Chloride Symporter Inhibitors/pharmacology , Symporters , Adrenalectomy , Aldosterone/administration & dosage , Androstanols/pharmacology , Animals , Bendroflumethiazide/pharmacology , Body Weight/drug effects , Dexamethasone/administration & dosage , Dexamethasone/pharmacology , Diuretics , Fludrocortisone/pharmacology , Kidney/drug effects , Kidney Tubules/metabolism , Male , Metolazone/metabolism , Potassium/blood , Potassium/urine , Rats , Rats, Inbred WKY , Rats, Sprague-Dawley , Sodium Chloride/blood , Sodium Chloride/urine , Sodium Chloride Symporters , Solute Carrier Family 12, Member 3 , Thymus Gland/drug effectsABSTRACT
A 30-kDa surface antigen was identified by Western blots with human immune sera in all 15 isolates of E. histolytica from patients with invasive amebiasis (pathogenic) but not in 15 strains from asymptomatic patients (nonpathogenic). This antigen is highly immunogenic in naturally infected humans and was recognized by sera from 22 patients with invasive disease but not by sera from 13 patients harboring nonpathogenic strains. Its surface location is supported by its differential extraction in the detergent phase of Triton X-114 and by surface immunofluorescence of live trophozoites. Unlike previously described amebic surface antigens, this 30-kDa antigen is undetectable in axenic strains that were originally isolated from patients with invasive disease but have been adapted to grow without bacteria. Affinity-purified antibody to the 30-kDa antigen did not promote lysis of complement-resistant pathogenic strains. This surface antigen may be diagnostically important in the identification of pathogenic clinical isolates.
Subject(s)
Amebiasis/parasitology , Antigens, Protozoan/analysis , Entamoeba histolytica/immunology , Entamoebiasis/parasitology , Animals , Antigens, Protozoan/immunology , Antigens, Surface/analysis , Antigens, Surface/immunology , Blotting, Western , Entamoeba histolytica/pathogenicity , Entamoebiasis/immunology , Fluorescent Antibody Technique , Humans , Immune Sera/immunologyABSTRACT
Murine stocks with wild-derived hypoxanthine phosphoribosyltransferase (HPRT) A alleles (Hprt a) have erythrocyte HPRT activity levels that are approximately 25-fold (Mus musculus castaneus) and 70-fold (Mus spretus) higher than those of laboratory strains of mice with the common Hprt b allele (Mus musculus: C3H/HeHa or C57B1/6). Since the purified HPRT A and B enzymes have substantially similar maximal specific activities (64 and 46 units/mg of protein, respectively), we infer that these HPRT activity levels closely approximate the relative levels of HPRT protein in these cells. Red blood cells of HPRT A and B mice have similar levels of adenine phosphoribosyltransferase activity (APRT; EC 2.4.2.7) and reticulocyte percentages, which suggests that the elevated levels of HPRT in erythrocytes of HPRT A mice are not secondary consequences of abnormal erythroid cell development. The HPRT activity levels in reticulocytes of HPRT B mice are approximately 35-fold higher than the levels in their erythrocytes and approach the HPRT activity levels in reticulocytes of HPRT A mice. Thus, the marked differences in the levels of HPRT protein in erythrocytes of HPRT A and B mice result from differences in the extent to which the HPRT A and B proteins are retained as reticulocytes mature to erythrocytes. The substantial and preferential loss of HPRT B activity from reticulocytes is paralleled by an equivalent loss of HPRT immunoreactive protein (i.e., CRM) from that cell, and we infer that the HPRT B protein is degraded or extruded as reticulocytes mature to erythrocytes.(ABSTRACT TRUNCATED AT 250 WORDS)